# Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.

> **NCT03762408** · NA · COMPLETED · sponsor: **OPKO Health, Inc.** · enrollment: 175 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DEVICE:** ENKO 1
- **DEVICE:** Durolane

## Key facts

- **NCT ID:** NCT03762408
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-15
- **Primary completion:** 2020-05-29
- **Final completion:** 2020-05-29
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2021-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03762408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03762408, "Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03762408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*